Report Detail
Global (United States, European Union and China) At-Home Drug of Abuse (DOA) Testing Market Research Report 2019-2025
- RnM3665999 |
- 13 August, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Chemical & Material
The at-home DOA testing market has been categorized into rapid DOA test kits and breath analyzers.
The market is mainly driven by the increased production and trade of illicit drugs worldwide, growing use of illicit drugs amongst teenagers, and initiatives by government organizations to reduce the level of drug abuse.
In 2019, the market size of At-Home Drug of Abuse (DOA) Testing is 430 million US$ and it will reach 950 million US$ in 2025, growing at a CAGR of 10.6% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for At-Home Drug of Abuse (DOA) Testing.
This report studies the global market size of At-Home Drug of Abuse (DOA) Testing, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the At-Home Drug of Abuse (DOA) Testing production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
UCP Biosciences
Orient New Life Medical
Express Diagnostics Int’l
Assure Tech (Hangzhou)
Psychemedics Corporation
Confirm BioSciences
Phamatech
Home Health (U.K.) Ltd.
Quest Products
Market Segment by Product Type
Test Cups
Test Dip Cards
Test Strips
Others
Market Segment by Application
Urine
Saliva
Hair
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the At-Home Drug of Abuse (DOA) Testing status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key At-Home Drug of Abuse (DOA) Testing manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of At-Home Drug of Abuse (DOA) Testing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Research Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global At-Home Drug of Abuse (DOA) Testing Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Test Cups
- 1.3.3 Test Dip Cards
- 1.3.4 Test Strips
- 1.3.5 Others
- 1.4 Market Segment by Application
- 1.4.1 Global At-Home Drug of Abuse (DOA) Testing Market Share by Application (2019-2025)
- 1.4.2 Urine
- 1.4.3 Saliva
- 1.4.4 Hair
- 1.4.5 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Production and Capacity Analysis
- 2.1.1 Global At-Home Drug of Abuse (DOA) Testing Production Value 2014-2025
- 2.1.2 Global At-Home Drug of Abuse (DOA) Testing Production 2014-2025
- 2.1.3 Global At-Home Drug of Abuse (DOA) Testing Capacity 2014-2025
- 2.1.4 Global At-Home Drug of Abuse (DOA) Testing Marketing Pricing and Trends
- 2.2 Key Producers Growth Rate (CAGR) 2019-2025
- 2.2.1 Global At-Home Drug of Abuse (DOA) Testing Market Size CAGR of Key Regions
- 2.2.2 Global At-Home Drug of Abuse (DOA) Testing Market Share of Key Regions
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Capacity and Production by Manufacturers
- 3.1.1 Global At-Home Drug of Abuse (DOA) Testing Capacity by Manufacturers
- 3.1.2 Global At-Home Drug of Abuse (DOA) Testing Production by Manufacturers
- 3.2 Revenue by Manufacturers
- 3.2.1 At-Home Drug of Abuse (DOA) Testing Revenue by Manufacturers (2014-2019)
- 3.2.2 At-Home Drug of Abuse (DOA) Testing Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global At-Home Drug of Abuse (DOA) Testing Market Concentration Ratio (CR5 and HHI)
- 3.3 At-Home Drug of Abuse (DOA) Testing Price by Manufacturers
- 3.4 Key Manufacturers At-Home Drug of Abuse (DOA) Testing Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into At-Home Drug of Abuse (DOA) Testing Market
- 3.6 Key Manufacturers At-Home Drug of Abuse (DOA) Testing Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Production and Production Value for Each Type
- 4.1.1 Test Cups Production and Production Value (2014-2019)
- 4.1.2 Test Dip Cards Production and Production Value (2014-2019)
- 4.1.3 Test Strips Production and Production Value (2014-2019)
- 4.1.4 Others Production and Production Value (2014-2019)
- 4.2 Global At-Home Drug of Abuse (DOA) Testing Production Market Share by Type
- 4.3 Global At-Home Drug of Abuse (DOA) Testing Production Value Market Share by Type
- 4.4 At-Home Drug of Abuse (DOA) Testing Ex-factory Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global At-Home Drug of Abuse (DOA) Testing Consumption by Application
6 Production by Regions
- 6.1 Global At-Home Drug of Abuse (DOA) Testing Production (History Data) by Regions 2014-2019
- 6.2 Global At-Home Drug of Abuse (DOA) Testing Production Value (History Data) by Regions
- 6.3 United States
- 6.3.1 United States At-Home Drug of Abuse (DOA) Testing Production Growth Rate 2014-2019
- 6.3.2 United States At-Home Drug of Abuse (DOA) Testing Production Value Growth Rate 2014-2019
- 6.3.3 Key Players in United States
- 6.3.4 United States At-Home Drug of Abuse (DOA) Testing Import & Export
- 6.4 European Union
- 6.4.1 European Union At-Home Drug of Abuse (DOA) Testing Production Growth Rate 2014-2019
- 6.4.2 European Union At-Home Drug of Abuse (DOA) Testing Production Value Growth Rate 2014-2019
- 6.4.3 Key Players in European Union
- 6.4.4 European Union At-Home Drug of Abuse (DOA) Testing Import & Export
- 6.5 China
- 6.5.1 China At-Home Drug of Abuse (DOA) Testing Production Growth Rate 2014-2019
- 6.5.2 China At-Home Drug of Abuse (DOA) Testing Production Value Growth Rate 2014-2019
- 6.5.3 Key Players in China
- 6.5.4 China At-Home Drug of Abuse (DOA) Testing Import & Export
- 6.6 Rest of World
- 6.6.1 Japan
- 6.6.2 Korea
- 6.6.3 India
- 6.6.4 Southeast Asia
7 At-Home Drug of Abuse (DOA) Testing Consumption by Regions
- 7.1 Global At-Home Drug of Abuse (DOA) Testing Consumption (History Data) by Regions
- 7.2 United States
- 7.2.1 United States At-Home Drug of Abuse (DOA) Testing Consumption by Type
- 7.2.2 United States At-Home Drug of Abuse (DOA) Testing Consumption by Application
- 7.3 European Union
- 7.3.1 European Union At-Home Drug of Abuse (DOA) Testing Consumption by Type
- 7.3.2 European Union At-Home Drug of Abuse (DOA) Testing Consumption by Application
- 7.4 China
- 7.4.1 China At-Home Drug of Abuse (DOA) Testing Consumption by Type
- 7.4.2 China At-Home Drug of Abuse (DOA) Testing Consumption by Application
- 7.5 Rest of World
- 7.5.1 Rest of World At-Home Drug of Abuse (DOA) Testing Consumption by Type
- 7.5.2 Rest of World At-Home Drug of Abuse (DOA) Testing Consumption by Application
- 7.5.1 Japan
- 7.5.2 Korea
- 7.5.3 India
- 7.5.4 Southeast Asia
8 Company Profiles
- 8.1 UCP Biosciences
- 8.1.1 UCP Biosciences Company Details
- 8.1.2 Company Description and Business Overview
- 8.1.3 Production and Revenue of At-Home Drug of Abuse (DOA) Testing
- 8.1.4 At-Home Drug of Abuse (DOA) Testing Product Introduction
- 8.1.5 UCP Biosciences Recent Development
- 8.2 Orient New Life Medical
- 8.2.1 Orient New Life Medical Company Details
- 8.2.2 Company Description and Business Overview
- 8.2.3 Production and Revenue of At-Home Drug of Abuse (DOA) Testing
- 8.2.4 At-Home Drug of Abuse (DOA) Testing Product Introduction
- 8.2.5 Orient New Life Medical Recent Development
- 8.3 Express Diagnostics Int’l
- 8.3.1 Express Diagnostics Int’l Company Details
- 8.3.2 Company Description and Business Overview
- 8.3.3 Production and Revenue of At-Home Drug of Abuse (DOA) Testing
- 8.3.4 At-Home Drug of Abuse (DOA) Testing Product Introduction
- 8.3.5 Express Diagnostics Int’l Recent Development
- 8.4 Assure Tech (Hangzhou)
- 8.4.1 Assure Tech (Hangzhou) Company Details
- 8.4.2 Company Description and Business Overview
- 8.4.3 Production and Revenue of At-Home Drug of Abuse (DOA) Testing
- 8.4.4 At-Home Drug of Abuse (DOA) Testing Product Introduction
- 8.4.5 Assure Tech (Hangzhou) Recent Development
- 8.5 Psychemedics Corporation
- 8.5.1 Psychemedics Corporation Company Details
- 8.5.2 Company Description and Business Overview
- 8.5.3 Production and Revenue of At-Home Drug of Abuse (DOA) Testing
- 8.5.4 At-Home Drug of Abuse (DOA) Testing Product Introduction
- 8.5.5 Psychemedics Corporation Recent Development
- 8.6 Confirm BioSciences
- 8.6.1 Confirm BioSciences Company Details
- 8.6.2 Company Description and Business Overview
- 8.6.3 Production and Revenue of At-Home Drug of Abuse (DOA) Testing
- 8.6.4 At-Home Drug of Abuse (DOA) Testing Product Introduction
- 8.6.5 Confirm BioSciences Recent Development
- 8.7 Phamatech
- 8.7.1 Phamatech Company Details
- 8.7.2 Company Description and Business Overview
- 8.7.3 Production and Revenue of At-Home Drug of Abuse (DOA) Testing
- 8.7.4 At-Home Drug of Abuse (DOA) Testing Product Introduction
- 8.7.5 Phamatech Recent Development
- 8.8 Home Health (U.K.) Ltd.
- 8.8.1 Home Health (U.K.) Ltd. Company Details
- 8.8.2 Company Description and Business Overview
- 8.8.3 Production and Revenue of At-Home Drug of Abuse (DOA) Testing
- 8.8.4 At-Home Drug of Abuse (DOA) Testing Product Introduction
- 8.8.5 Home Health (U.K.) Ltd. Recent Development
- 8.9 Quest Products
- 8.9.1 Quest Products Company Details
- 8.9.2 Company Description and Business Overview
- 8.9.3 Production and Revenue of At-Home Drug of Abuse (DOA) Testing
- 8.9.4 At-Home Drug of Abuse (DOA) Testing Product Introduction
- 8.9.5 Quest Products Recent Development
9 Market Forecast
- 9.1 Global Market Size Forecast
- 9.1.1 Global At-Home Drug of Abuse (DOA) Testing Capacity, Production Forecast 2019-2025
- 9.1.2 Global At-Home Drug of Abuse (DOA) Testing Production Value Forecast 2019-2025
- 9.2 Market Forecast by Regions
- 9.2.1 Global At-Home Drug of Abuse (DOA) Testing Production and Value Forecast by Regions 2019-2025
- 9.2.2 Global At-Home Drug of Abuse (DOA) Testing Consumption Forecast by Regions 2019-2025
- 9.3 United States
- 9.3.1 Production and Value Forecast in United States
- 9.3.2 Consumption Forecast in United States
- 9.4 European Union
- 9.4.1 Production and Value Forecast in European Union
- 9.4.2 Consumption Forecast in European Union
- 9.5 China
- 9.5.1 Production and Value Forecast in China
- 9.5.2 Consumption Forecast in China
- 9.6 Rest of World
- 9.6.1 Japan
- 9.6.2 Korea
- 9.6.3 India
- 9.6.4 Southeast Asia
- 9.7 Forecast by Type
- 9.7.1 Global At-Home Drug of Abuse (DOA) Testing Production Forecast by Type
- 9.7.2 Global At-Home Drug of Abuse (DOA) Testing Production Value Forecast by Type
- 9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
- 10.1 Value Chain Analysis
- 10.2 Sales Channels Analysis
- 10.2.1 At-Home Drug of Abuse (DOA) Testing Sales Channels
- 10.2.2 At-Home Drug of Abuse (DOA) Testing Distributors
- 10.3 At-Home Drug of Abuse (DOA) Testing Customers
11 Opportunities & Challenges, Threat and Affecting Factors
- 11.1 Market Opportunities
- 11.2 Market Challenges
- 11.3 Porter's Five Forces Analysis
12 Key Findings
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.1.1 Research Programs/Design
- 13.1.1.2 Market Size Estimation
- 13.1.1.3 Market Breakdown and Data Triangulation
- 13.1.2 Data Source
- 13.1.2.1 Secondary Sources
- 13.1.2.2 Primary Sources
- 13.1.1 Methodology/Research Approach
- 13.2 Author Details
Summary:
Get latest Market Research Reports on At-HomeDrugofAbuse(DOA)Testing. Industry analysis & Market Report on At-HomeDrugofAbuse(DOA)Testing is a syndicated market report, published as Global (United States, European Union and China) At-Home Drug of Abuse (DOA) Testing Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of At-HomeDrugofAbuse(DOA)Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
